Order Article Reprints

Hendricks A, Amallraja A, Meißner T, Forster P, Rosenstiel P, Burmeister G, Schafmayer C, Franke A, Hinz S, Forster M, et al. Stage IV Colorectal Cancer Patients with High Risk Mutation Profiles Survived 16 Months Longer with Individualized Therapies. Cancers. 2020; 12(2):393. https://doi.org/10.3390/cancers12020393

Hendricks, Alexander, Anu Amallraja, Tobias Meißner, Peter Forster, Philip Rosenstiel, Greta Burmeister, Clemens Schafmayer, Andre Franke, Sebastian Hinz, Michael Forster, and et al. 2020. "Stage IV Colorectal Cancer Patients with High Risk Mutation Profiles Survived 16 Months Longer with Individualized Therapies" Cancers 12, no. 2: 393. https://doi.org/10.3390/cancers12020393

Hendricks, A., Amallraja, A., Meißner, T., Forster, P., Rosenstiel, P., Burmeister, G., Schafmayer, C., Franke, A., Hinz, S., Forster, M., & Williams, C. B. (2020). Stage IV Colorectal Cancer Patients with High Risk Mutation Profiles Survived 16 Months Longer with Individualized Therapies. Cancers, 12(2), 393. https://doi.org/10.3390/cancers12020393